ArticleScience translational medicine2014

Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase.

Yan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.